CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
Through the years, many promising tools for gene editing have been developed including zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), CRISPR-associated protein 9 (Cas9), and homing endonucleases (HEs). These novel technologies are now leading new scientific a...
Guardado en:
Autores principales: | Sahar Serajian, Ehsan Ahmadpour, Sonia M. Rodrigues Oliveira, Maria de Lourdes Pereira, Siamak Heidarzadeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed5081de19ea4c7fb466d5014f7e1f4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Applications of CRISPR-Cas Technologies to Proteomics
por: Georgii Dolgalev, et al.
Publicado: (2021) -
Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple <italic toggle="yes">Candida</italic> Species
por: Lisa Lombardi, et al.
Publicado: (2019) -
CRISPR and KRAS: a match yet to be made
por: Guzide Bender, et al.
Publicado: (2021) -
Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infection
por: Joonhyeok Choi, et al.
Publicado: (2021) -
Nanotechnology-Based Delivery Systems for Antimicrobial Peptides
por: Adewale Oluwaseun Fadaka, et al.
Publicado: (2021)